Skip to content
Study details
Enrolling now

EQUITY GI Trial

Case Comprehensive Cancer Center
NCT IDNCT06263088ClinicalTrials.gov data as of Apr 2026
Target enrollment

200

Study length

about 1.6 years

Ages

18+

Locations

1 site in OH

What this study is about

Researchers are testing a way to improve the quality of care and participation in clinical trials for Black patients with gastrointestinal cancer. The trial will focus on ensuring appropriate biomarker testing, providing assistance with enrollment in relevant clinical trials, and improving health literacy about their condition and treatment options.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.EQUITY GI

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Biomarker testing rate of Black participants diagnosed with GI cancer

Body systems

Oncology